![]() Neon Therapeutics Neon Therapeutics is a clinical-stage immuno-oncology company and specializes in the field of neoantigen-targeted therapies, dedicated to transforming the treatment of cancer by directing the immune system towards neoantigens. | ![]() Guardant Health Guardant Health is a company that specializes in non-invasive cancer diagnostics and comprehensive genomic liquid biopsy. | ![]() Burning Rock Biotech Burning Rock Biotech (燃石医学) is a company that specializes in next-generation sequencing (NGS) diagnostics solutions for precision medicine in oncology. | ![]() BC Cancer BC Cancer is a provider of a province-wide cancer control program in partnership with regional health authorities. | Hygeia Healthcare Holdings Hygeia Healthcare Holdings (海吉亚医疗控股有限公司) is a provider of oncology healthcare solutions. | |
Founding Date | Founding Date 2015 | Founding Date 2012 | Founding Date 2014 | Founding Date 1938 | Founding Date 2009 |
Type | Type Subsidiary | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Cambridge, US HQ | Locations Redwood City, US HQ | Locations Guang Zhou, CN HQ Beijing, CN Shanghai, CN Irvine, US | Locations Vancouver, CA HQ | Locations Shanghai, CN HQ |
Employees | Employees 7130% decrease | Employees 1,7681% decrease | Employees 674 | Employees 2,4391% increase | Employees 8,169 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 2.7 b | Valuation ($) 28.6 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $982m (FY, 2025) | Revenue (est.) ¥539.6m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ¥4b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $349m (FY, 2025) | Cost of goods ¥114.9m (FY, 2025) | Cost of goods N/A | Cost of goods ¥2.7b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $633m (FY, 2025) | Gross profit ¥424.7m (FY, 2025) | Gross profit N/A | Gross profit ¥1.4b (FY, 2025) |
Net income | Net income ($79.8m) (FY, 2019) | Net income ($416.3m) (FY, 2025) | Net income (¥55.3m) (FY, 2025) | Net income N/A | Net income ¥161.5m (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 161m | Total funding raised $ 550m | Total funding raised $ 149.2m | Total funding raised N/A | Total funding raised N/A |

Guardant Health is a company that specializes in non-invasive cancer diagnostics and comprehensive genomic liquid biopsy.
View company
Burning Rock Biotech (燃石医学) is a company that specializes in next-generation sequencing (NGS) diagnostics solutions for precision medicine in oncology.
View company
BC Cancer is a provider of a province-wide cancer control program in partnership with regional health authorities.
View companyHygeia Healthcare Holdings (海吉亚医疗控股有限公司) is a provider of oncology healthcare solutions.
View company